BIOS-0619

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBIOS-0619
Drug Alias NameBIOS-0619
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 4 modulatorsCyclin-dependent kinase 6 modulators
TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 6
Therapy Area/IndicationsBreast NeoplasmsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Bio-Sincerity Pharma-Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Bio-Sincerity Pharma-Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A